Leukocyte-rich platelet-rich plasma (LR-PRP) and Leukocyte-poor platelet-rich plasma (LP-PRP)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leukocyte-rich platelet-rich plasma (LR-PRP) and Leukocyte-poor platelet-rich plasma (LP-PRP), covering 2023-02-21 to 2023-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee [Phase 2, Phase 3]